Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001047469-02-007971
Filing Date
2002-12-23
Accepted
2002-12-20 20:56:19
Documents
6
Period of Report
2002-09-30

Document Format Files

Seq Description Document Type Size
1 10-K a2096541z10-k.htm 10-K 208239
3 EX-13.1 a2096541zex-13_1.htm EX-13.1 1605708
4 EXHIBIT 23.1 a2096541zex-23_1.htm EX-23.1 3162
5 EXHIBIT 99.1 a2096541zex-99_1.htm EX-99.1 2979
6 EXHIBIT 99.2 a2096541zex-99_2.htm EX-99.2 2973
7 EX13-1AA1892IMAGE001.JPG ex13-1aa1892image001.jpg GRAPHIC 34210
  Complete submission text file 0001047469-02-007971.txt   1859419
Mailing Address 8899 UNIVERSITY CENTER LANE STE 400 SAN DIEGO CA 92122
Business Address 8899 UNIVERSITY CTR LANE STE 400 SAN DIEGO CA 92122 8584534040
MAXIM PHARMACEUTICALS INC (Filer) CIK: 0001013351 (see all company filings)

EIN.: 870279983 | State of Incorp.: DE | Fiscal Year End: 0930
Type: 10-K | Act: 34 | File No.: 001-14430 | Film No.: 02866002
SIC: 2833 Medicinal Chemicals & Botanical Products